The Technical Analyst
Select Language :
Mersana Therapeutics Inc [MRSN]

Exchange: Nasdaq Global Select Sector: Healthcare Industry: Biotechnology

Mersana Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Mersana Therapeutics Inc is listed at the NASDAQ Exchange

3.69% $3.09

Last updated: 16 May 2022 @ 10:48 am


FUNDAMENTALS
MarketCap: 299.70 mill
EPS: -2.41
P/E: 0.000
Earnings Date: Aug 04, 2022
SharesOutstanding: 96.99 mill
Avg Daily Volume: 1.583 mill
RATING 2022-05-13
A-
Buy
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenuen/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$5.57
(80.26%) $2.48
Date: 2022-05-16
True Range Average
+/- $0.349
( +/- 11.71%)
Range: 2.63 - 3.33
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-04-26 Carvajal Alejandra Sell 13 250 Restricted stock unit
2022-04-26 Carvajal Alejandra Sell 3 948 Common Stock
2022-04-26 Carvajal Alejandra Sell 13 250 Restricted stock unit
2022-04-13 Hack Andrew A. F. Buy 617 284 Common Stock
2022-04-12 Hack Andrew A. F. Buy 598 086 Common Stock
INSIDER POWER
81.74
Last 100 transactions
Buy: 5 705 208 | Sell: 578 682

Forecast: 12:27 - $3.10

Live Trading Signals (every 1 min)

Forecast 1: 10:57 - $3.09
Forecast 2: 11:47 - $3.14
Forecast 3: 12:27 - $3.10
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.09 (3.69% )
Volume 0.182 mill
Avg. Vol. 1.583 mill
% of Avg. Vol 11.50 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Mersana Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Mersana Therapeutics Inc

RSI

Intraday RSI14 chart for Mersana Therapeutics Inc

Last 10 Buy & Sell Signals For MRSN

167 Signals | Accuracy: 28.14% | Accuracy Buy: 31.33% | Accuracy Sell: 25.00%

Avg return buy: 0.12 % | Avg return sell: -0.34 %

$1 invested is now $1.10 or 9.66% since 20-04-22

Date Signal @ Closed %
May 16 - 10:20buy$3.10N/AActive
May 13 - 12:36sell$3.16$3.08 @ May 16 - 10:19-2.53%
May 13 - 12:31buy$3.18$3.17 @ May 13 - 12:34-0.16%
May 13 - 12:25sell$3.16$3.18 @ May 13 - 12:300.47%
May 13 - 12:06buy$3.17$3.17 @ May 13 - 12:210.08%
May 13 - 11:36sell$3.18$3.17 @ May 13 - 12:05-0.31%
May 13 - 11:08buy$3.17$3.18 @ May 13 - 11:350.32%
May 13 - 11:02sell$3.15$3.17 @ May 13 - 11:080.48%
May 13 - 10:26buy$3.12$3.14 @ May 13 - 10:460.64%
May 13 - 10:17sell$3.10$3.12 @ May 13 - 10:250.65%
The Live Chart for Mersana Therapeutics Inc
Profile picture for
            Mersana Therapeutics Inc

MRSN

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of antibody drug conjugate (ADC) for cancer patients with unmet need. The company develops Dolaflexin, a platform, which is used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not amenable to treat with traditional ADC-based therapies. Its lead product candidate is XMT-1536, a Dolaflexin ADC targeting NaPi2b that is in Phase I clinical trial for the treatment of patients with ovarian cancer, non small cell lung cancer, and other orphan indications. Mersana Therapeutics, Inc. has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is based in Cambridge, Massachusetts.

Last 10 Buy Signals
Date Signal @
VGLTMay 16 - 10:46$71.19
VGITMay 16 - 10:46$61.56
ULHMay 16 - 10:46$26.51
TLTMay 16 - 10:46$116.47
SYTAMay 16 - 10:46$1.040
TBCPMay 16 - 10:46$9.79
SXTCMay 16 - 10:46$0.168
TCDAMay 16 - 10:46$9.40
SIMOMay 16 - 10:44$92.34
SHBIMay 16 - 10:46$19.29

Stock Peers

Company Price Change
MRSN3.093.69%
BLFS12.15-2.17%
CHRS7.93-0.25%
CLDX29.79-0.67%
KNTE9.593.68%
LMAT43.951.54%
MNKD3.113.16%
MNMD0.8113.95%
SIBN12.540.32%
SRRK5.620.63%
ZGNX26.680.00%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.